ARIX - Ticker AI Digest

Arix Bioscience PLC ๐Ÿ“ฐ 1
Desk Snapshot GO VIP Login
Important AI Risk Notice

Charts, catalyst summaries, AI scores, forecasts and price context are AI-driven and can hallucinate, lag or miss market-changing information.

Not investment advice. Markets can move fast and any trade or allocation decision remains your responsibility.
AI can hallucinate. Summaries, rankings, forecasts and commentary can be wrong, incomplete or misleading.
AI-driven data only. Signals, dates, prices, sentiment and automation outputs may be delayed, estimated or stale.
Always verify externally. Confirm prices, filings, broker notes and trade setup details with independent sources before acting.
Mobile Command Deck
Arix Bioscience PLC in one cleaner mobile flow.
Tap straight into the module you want. No sideways tab hunt, just a clean route into charts, news, Today’s AI, and the deeper desks.
ARIX Data 2022-08-12 Preview Mode
Core Deck
Deep Dive Modules

Digested News

Today's Catalysts (ARIX) 1
ARIX 06:01
Arix Bioscience PLC
Unaudited NAV for July 2022
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 1
ARIX 16:47
Arix Bioscience PLC
Portfolio Company Disc Medicine Enters Definitive Merger Agreement with Gemini Therapeutics
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 2
ARIX 06:01
Arix Bioscience PLC
Interim Results for the Six Months Ended 30 June 2022
ARIX 06:01
Arix Bioscience PLC
Notice of Results & Investor Presentation
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 0
No items for this category on selected date.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 7
ARIX 06:01
Arix Bioscience PLC
Unaudited NAV for July 2022
ARIX 17:06
Arix Bioscience PLC
Artios initiates Phase 2 study of Polฮธ Inhibitor ART4215 in Combination with PARP Inhibitor Talazoparib in BRCA Deficient Breast Cancer
ARIX 16:47
Arix Bioscience PLC
Portfolio Company Disc Medicine Enters Definitive Merger Agreement with Gemini Therapeutics
ARIX 06:02
Arix Bioscience PLC
Arix Bioscience plc Announces Changes to Board of Directors
ARIX 06:01
Arix Bioscience PLC
Interim Results for the Six Months Ended 30 June 2022
ARIX 06:01
Arix Bioscience PLC
Notice of Results & Investor Presentation
ARIX 06:01
Arix Bioscience PLC
Unaudited NAV for June 2022

Today's AI

Today's AI Starts With News

1 live catalyst is opening Today’s AI for ARIX.

Start with the live headline tape first. Today’s AI findings sit next, and the AI Blend stack drops lower once the news context is framed. Financial Forecastist now feeds the blend too.
Live Tape Data 2022-08-12 Blend Lower Down
Read the alert tape first, then open Today’s AI findings. Use AI Expand on any card to open the AI explanation, results tables and financial forecast rows instantly.
1 Today
Front Of Desk
Arix Bioscience PLC has fresh news flow live now, so Today’s AI is leading with the tape before the blended signal stack below.
06:01 Today's Catalyst Unaudited NAV for July 2022
Single-Ticker Today's AI
ARIX signal theatre built from scored market catalysts, automated AI forecasts, financial forecasting and live trigger logic.

This is the ticker-specific Today’s AI desk for Arix Bioscience PLC. It compresses the live catalyst tape, bullish and bearish scoring, AI price forecasts, financial forecasting and trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI + Financial Blend Buy / Sell Trigger Engine Today's AI Findings
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full ARIX Today’s AI cockpit.

Subscription turns this tab into a live signal desk with today’s news findings at the top, AI plus financial blend comparisons at the bottom, buy and sell trigger logic, and the full findings ledger behind every scored row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific Today’s AI stack, sentiment gauges, AI blend stage, and the full findings ledger for ARIX on 2022-08-12.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
185.7M
Enterprise Value
11.1M
Public Float
48.3
Broker Target
115
Shares Out
129.4M
Long Interest
0
Short Interest
0
Exchange
LSE
Currency Code
GBX
ISIN
GB00BD045071
Market
LSE - MAIN MARKET
Sector
Financial Services
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

News And Alerts First

1 live alert now opens the financials desk for ARIX.

Start with the headline flow and alert tape first. Then drop straight into Financial Forecastist below for the revenue path, EPS shape, cash pressure and balance-sheet read while the catalyst context is still hot.
Live Alerts Data 2022-08-12 Forecastist Below
Read the alert tape first, then move into Financial Forecastist below. Use AI Expand on any catalyst card to open the AI explanation and results tables without losing the ticker context.
1 Alerts
Front Of Desk
Arix Bioscience PLC has fresh filing flow live now, so the tape is framing the revenue, leverage and valuation story below.
06:01 Today's Alert Unaudited NAV for July 2022
Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
-
Earnings Date
-
Net Debt
-122.7M
Cash
122.8M
EPS
0.11
Net Income
-27.6M
Revenue
14.2M
Enterprise Value
11.1M
Trailing PE
12.9091
Forward PE
3.6969
Price Sales TTM
13.1144
Price Book MRQ
0.7687
EV Revenue
1075.0922
EV EBITDA
-14.5487
Financial Forecastist

Improving financial engine

Revenue is accelerating +11453.0% against the prior comparable period. Net margin is expanding by 21,075.4 pts. Net debt is coming down +22.9%.

Revenue +11453.0% Net Income -132.4% FCF -13.1% Current Ratio 73.10x Forward Rev 0
Improving
Quarter Revenue
21.1M
+11453.0%
vs prior comparable quarter
Net Margin
+59.0%
+21075.4 pts
profitability pulse
Free Cash Flow
-1.8M
-13.1%
cash conversion
Net Debt / EBITDA
-5.5x
-22.9%
lower is cleaner
Revenue Engine

Latest quarter printed 21.1M with the top line pushing higher against the last comparable period.

Profit Stack

Net income landed at 12.5M and the margin profile is broadening. That usually tells us whether operating leverage is finally kicking in.

Balance-Sheet Pressure

Cash sits near 101.0M while net debt is -101.0M. The leverage stack is cleaning up.

Quarterly Revenue Runway

Actual revenue bars, consensus revenue where available, plus the terminal model path.

Profit And Cash Conversion

Net income and free cash flow moving together is usually what separates genuine improvement from noise.

Balance-Sheet Pressure

Cash, net debt and liquidity tell us whether the business is strengthening or just surviving.

Annual Power Curve

Longer-cycle revenue and net income help frame whether the company is compounding or rolling over.
Q3 2022
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q1 2023
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q2 2023
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q3 2023
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
FY 2023
Consensus
0
Revenue Path
18,815.50
EPS / Earnings
Growth cue -
FY 2024
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -

Quarterly Statement Tape

Last 6 Quarters
Period Revenue Net Income FCF Net Debt
Q2 2023 21.1M 12.5M -1.8M -101.0M
Q1 2023 7.9M 6.2M -921.0K -101.0M
Q4 2022 50.0K 2.5M 35.0K -122.7M
Q3 2022 -812.0K 1.2M 17.5K -122.8M
Q2 2022 - - - -131.0M
Q1 2022 - - - -

Annual Financial Power

Last 5 Years
Period Revenue Net Income EBITDA FCF
FY 2022 112.0K -27.6M 25.7M -4.6M
FY 2021 340.0K -173.1M 51.2M -7.2M
FY 2020 477.0K 395.0M -142.1M -6.7M
FY 2019 506.0K -69.7M 47.1M -8.5M
FY 2018 1.3M 36.9M -64.4M -11.1M

Structure DNA

Market Structure DNA has not been loaded for this ticker yet. Once the A15 loader runs, this desk will light up with regime labels, ownership lock, dividend cadence, and structure charts.

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
129390000
Public Hands
48.26037792719685
Institutions
-
Institutions As Of
-
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
0
Sale Director Dealing
0
Purchase TR1
0
Sale TR1
0
Broker Coverage Rows
0
Institution Holders Tracked
0
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

News And Alerts First

The alert tape opens the door for ARIX, and AI Charts sits just below.

Start with the headline flow and live catalyst tape first. Then move straight into AI Charts below for price reaction, AI targets, chart structure and catalyst beacons while the news context is still hot.
Live Tape Data 2022-08-12 AI Charts Below
Read the alert tape first, then move into AI Charts below. Use AI Expand on any catalyst card to open the AI explanation and results tables instantly.
1 Today
Catalyst Pulse
Arix Bioscience PLC has fresh news flow live now, so the tape is framing the chart workspace below.
06:01 Today's Catalyst Unaudited NAV for July 2022
AI Charts Studio
ARIX Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2022-08-12 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
Desk Snapshot Member Login
Indicators0
Technicals0
RSI Gauge
Price Change
AI Forecast